The 19th annual Molecular Medicine Tri-Conference will bring together the therapeutic and diagnostic aspects of the molecular medicine industry to discuss cutting-edge research, trends and analysis. Areas of interest include molecular diagnostics, personalized diagnostics, cancer molecular markers, medicinal chemistry, circulating tumor cells, translational science, drug discovery, stem cells, cancer biologics, informatics, and oncology clinical trials.
Robert Hollingsworth will offer the chairperson's remarks for "From Therapeutic Discovery to the Clinic."
Theresa LaVallee will offer the chairperson's remarks for "Translational Imaging."
Brandon Higgs will present "Analytic and Regulatory Considerations for Cellular Biomarkers (of Disease and Therapy)."
Added by MedImmune on February 3, 2012